Quantitative Evaluation of Chinese Herb Medicine in the Treatment of Sialorrhea and Frequent Nighttime Urination in Patients with Parkinson’s Disease

Table 1

Basal characteristics of all patients with Parkinson’s disease.

	LSF ()	Placebo ()
Male/female	26/18	27/16
Age (y)	67.3 ± 9.6	66.8 ± 11.3
Age of PD onset (y)	60.5 ± 6.1	58.7 ± 7.3
Duration of PD diagnosis (y)	4.4 ± 3.3	4.7 ± 3.7
Baseline of NA (counts/min)	132.9 ± 36.5	130.3 ± 38.7
Baseline of QA (mL)	62.5 ± 36.9	62.1 ± 36.5
Baseline of FNU (times)	4.20 ± 1.7	4.18 ± 1.8
Baseline of ESA (counts/min)	166.8 ± 37.1	163.2 ± 39.4
Baseline of UPDRS	31.6 ± 6.7	31.3 ± 5.9
Baseline of ESS	9.9 ± 4.1	9.6 ± 5.2
Levodopa equivalent doses (mg)	361.6 ± 186.7	381.3 ± 175.9
Baseline of H & Y	2.5 ± 1.7	2.4 ± 1.8

Note. LSF: Lian-Se formula; PD: Parkinson’s disease; NA: nocturnal activity; QA: quantity saliva; FNU: frequent of nighttime urination; ESA: early sleep activity; UPDRS: unified Parkinson’s disease rating scale; ESS: Epworth Sleepiness Scale.